The Role of the ER-Induced UPR Pathway and the Efficacy of Its Inhibitors and Inducers in the Inhibition of Tumor Progression

Abstract EN

Cancer is the second most frequent cause of death worldwide.

It is considered to be one of the most dangerous diseases, and there is still no effective treatment for many types of cancer.

Since cancerous cells have a high proliferation rate, it is pivotal for their proper functioning to have the well-functioning protein machinery.

Correct protein processing and folding are crucial to maintain tumor homeostasis.

Endoplasmic reticulum (ER) stress is one of the leading factors that cause disturbances in these processes.

It is induced by impaired function of the ER and accumulation of unfolded proteins.

Induction of ER stress affects many molecular pathways that cause the unfolded protein response (UPR).

This is the way in which cells can adapt to the new conditions, but when ER stress cannot be resolved, the UPR induces cell death.

The molecular mechanisms of this double-edged sword process are involved in the transition of the UPR either in a cell protection mechanism or in apoptosis.

However, this process remains poorly understood but seems to be crucial in the treatment of many diseases that are related to ER stress.

Hence, understanding the ER stress response, especially in the aspect of pathological consequences of UPR, has the potential to allow us to develop novel therapies and new diagnostic and prognostic markers for cancer.